MANP (ZD100) is a novel best-in-class designer pGC-A/ cGMP activator engineered at the Mayo Clinic for the treatment of resistant hypertension for which there is no FDA approved drug. MANP… Click to show full abstract
MANP (ZD100) is a novel best-in-class designer pGC-A/ cGMP activator engineered at the Mayo Clinic for the treatment of resistant hypertension for which there is no FDA approved drug. MANP has recently been tested in a Phase 1 clinical trial and was blood pressure (BP) lowering, safe and well
               
Click one of the above tabs to view related content.